In the 20 years from 2000 to 2020, even after accounting for inflation, lobbyist spending in the US healthcare industry increased by more than 70%, with a sizeable chunk of that spending focused on pharmaceuticals and healthcare providers, according to recent data published in JAMA Health Forum.

Researchers used OpenSecrets, a non-profit, non-partisan organisation that tracks money in politics, to focus on four major categories of stakeholders: producers of pharmaceuticals and healthcare products, funders (insurers and health maintenance organisations), suppliers (health professionals, hospitals, nursing homes, and affiliated trade organisations), and other healthcare consultants and policy organisations.

Spending on lobbying climbed across the board, with rates of growth that were greater before 2010.

Healthcare lobbying costs totaled $713.6 million in 2020, compared to $358.2 million in 2000. Manufacturers of pharmaceutical and healthcare products spent $308,4 million in lobbying actions in 2020, followed by clinicians ($286.9 million), payers ($80.6 million), and other businesses ($37.7 million).

The top 10% of corporations accounted for 70.4% of payer spending, 69.0% of manufacturer spending, and 59.0% of provider spending, demonstrating the severe concentration of spending.

The top 10% of companies spent less, with the bottom 90% accounting for only 37.7% of the total. Statistics indicate that pharmaceutical and healthcare providers, as well as the trade associations that represent them, account for the majority of lobbying costs in the healthcare sector.

Similar disparities existed in the allocation of lobbying activities, with a small number of businesses footing the majority of the bill. Because of lobbying activities aimed at the Affordable Care Act, spending increase in the early 2000s was faster than in more subsequent years. The authors noted that because a small number of companies spend a disproportionate amount on lobbying, some groups may not be adequately represented while policies are being made.

Concerns that some businesses may be exerting an excessive degree of influence on policy-making have led to increased public scrutiny of lobbying actions in the U.S. healthcare sector, according to the authors. Hospitals and insurers are two more healthcare stakeholders that have come under regulatory oversight and may be spending money on lobbying efforts to further their interests.

Researchers from JAMA emphasised that it’s possible that not all lobbying costs were considered in the analysis. Additionally, while the majority of businesses simply disclose the costs related to federal lobbying, others also include state- and grassroots-level lobbying in their required disclosures.

According to the study, it was not always simple to differentiate between spending by companies with both healthcare and non-healthcare lines of business. OpenSecrets data, however, has been validated and used for research in other spheres of the economy.

In the United States, people 65 and over carry a disease burden far in excess ofmore than what could be achieved with effective lifestyle and therapeutic interventions. Proper management of common risk factors like obesity and diabetes could significantly reduce the high degree of suffering and costs associated with avoidable complications such as heart attack, heart failure, stroke, and kidney failure.

The facts surrounding healthcare for aging Americans are sobering. Consider:

• More than 10,000 people turn 65 in the United States every day. Given the myriad and advanced illnesses that many older adults cope with, the challenge for providers and payors in providing compassionate relief for these patients is daunting.
• Approximately 6 million people in the U.S. have cardiovascular disease. Nearly 50% of those people are older than 60. As our population ages, the resources needed to support these patients will be enormous.
• One in four physicians feel that lack of technology to accurately diagnose coronary artery disease (CAD) and peripheral artery disease (PAD) is a barrier to early and accurate diagnosis. Diagnostic delays result in avoidable suffering and costs.
• One in three healthcare leaders feel that a lack of standardization in diagnosing CAD/PAD is a barrier to accurate diagnosis.

Treating advanced disease of any kind is expensive and ultimately less effective than prevention or early intervention. We know that poorly managed chronic diseases like hypertension and diabetes are associated with, for example, heart failure and renal failure, and life-style changes coupled with proven diagnostic and therapeutic modalities can reduce the incidence and severity of these complications. Given these facts, how impactful could programs directed at these chronic diseases be in mitigating costs and human suffering? Extending the notion of prevention or preemption of complications by optimizing management to multiple disease states, could help in addressing societal goals around health equity and harnessing cost increases for our aging populations.

Moving Towards a Solution

How then can hospital administrators, providers, payors, and industry work with individual patients to deploy capabilities designed to improve clinical outcomes and medical costs? The answer is multitiered. We must:

• Address the variability in care associated with social circumstances, clinical inertia, and access/affordability
• Standardize protocols and outreach for screening high risk individuals
• Embrace personalized care with a focus on the individual characteristics and expectations of patients
• Target high-risk individuals with preventative preemptive care designed to halt disease progression and limit irreversible complications

Address care variability

Multiple factors influence the insidious variability in care delivered to populations. Social determinants require concrete and specific solutions, while excessive costs to patients need reform to limit out-of-pocket costs imposed by high premiums, deductibles, and coinsurance/copays. On the provider side, technological solutions that enhance decision making must be deployed, while incentives linking revenue to volume must be replaced by value-based payments that reward superior patient experience and clinical outcomes. A system designed to reward high-value services to patients across all ages would significantly impact the disease burden that the Centers for Medicare & Medicaid Services (CMS) encounters as patients become Medicare eligible.

Standardize screening of at-risk populations

Known modifiable risk factors are associated with significant morbidity, cost, and death.  Obesity clearly leads to risk linked to hypertension, diabetes, and hyperlipidemia, which in turn leads to serious cardiovascular morbidity. Screening for these risks is critical, and yet Abbott’s Beyond Intervention research revealed that the significant variability in screening is substantially affected by knowledge deficits in provider and patient communities around prioritization, access, and available tools. Missed opportunities to introduce lifestyle and clinical modifications lead to avoidable disease and cost progression.

Personalized care

Retailers offer clients goods targeted to their specific needs and preferences. Healthcare does not. Without personalized consideration of patient needs, prudent advice will be ignored, trust will erode, and outcomes will deteriorate. Currently we don’t have a system that bridges a public health orientation to a level of personalization that considers the clinical, social, and financial factors impacting a patient. The volume and completeness of data needed to personalize care is available but is prodigious and effectively uninterpretable by individual physicians and care givers. We need analytic and artificial intelligence (AI) expertise to convert those data to personalized insights and interventions. This challenge underscores the opportunity for AI to play a transformative role in advancing personalized and precise care.

Target patients through pre-emptive care

The classic rubric of population health management focuses on preventative care at one end of the illness spectrum, and catastrophic case management at the other. Along that continuum is an opportunity to support high-risk patients who require interventions tied to the emergence of disease states that have developed as a result of inadequate management of modifiable risk factors. If left unchecked, these disease states will result in catastrophic events like stroke and heart or renal failure. The notion of preemptive care highlights the need to effectively use the therapeutic and diagnostic tools at our disposal to stop the progression of chronic disease to irreversible end stage consequences.

With the Covid-19 restrictions easing, people have once again resumed their normal lives. The pandemic took a toll on all of us and children along with senior citizens were the worst victims of the disease due to the unavailability of Covid-19 vaccines. As online classes have ended and children have started going back to schools, there is an emerging trend of increasing viral infections among them, with many children falling ill more frequently than usual.

While the school reopening brought normalcy to the lives of the little ones, however, the gap of two years has compromised the immunity of the children. Due to the increased precautionary periods and a longer stay at home, many children have not been infected for a long time which is now taking a toll on them and is a probable cause behind them falling frequently ill.

Several cases of children with pre-existing health conditions and younger age groups have been found with increasing complaints of cough, allergies, viral infection, water-borne diseases, respiratory tract infections and gastrointestinal infections. This has highlighted the need for parents to take precautionary measures and adopt measures to boost the immunity of their children.

Precautionary measures that parents can take

Avoid Sedentary Lifestyle

According to a recent study, during the pandemic, the physical activity of school-going children had been reduced by 70% or less than 15 minutes a day, due to which their chances of falling sick have drastically increased. Leading a sedentary lifestyle can be dangerous for both kids and adults as it not only increases obesity but also gives rise to chronic illnesses.

Therefore, as we normalize, it has become critical for parents to limit the screen time of children and ensure that they get at least 60 mins of moderate to vigorous physical activity every day. A sedentary lifestyle not only impacts the child’s immunity but also hinders their physical growth. Hence, ensuring a balance between playtime and studies is now extremely critical for the parents.

Ensure regular and sleep cycle

For over two years children have been battling with irregular sleep cycles which is also a probable cause behind their poor immunity. The pandemic not only increased the screen time of the children but also made it difficult for them to keep up with their routines.

Parents must ensure that their child gets sufficient sleep which is essential for their immune system. Maintaining a proper sleep cycle helps in strengthening a strong innate and adaptive immunity and can also help the children in avoiding any severe allergic reactions.

Adopt a balanced diet and hygiene practices

Dr. Chetan Ginigeri, added, “Children love to eat unhealthy foods like pizza, burgers and colas etc. This often leads to obesity among them and increases their chances of inflammation. Parents need to understand that regular consumption of a diet with high additives, preservatives and sugar can weaken their child’s immunity. Therefore, parents must develop a practice to include at least 5 vegetables in their family’s diet every day that can boost the child’s immunity and improve his/her digestion. Additionally, teaching healthy hygiene practices to your child at home will ensure that they will follow similar measures at school. Teaching your child the proper hand hygiene practices will prevent them from dirt and dust and other gastrointestinal infections”.

It is also important to note that on average school-going kids can have five to six colds a year and hence, parents must avoid panicking if they notice any symptoms. If your child is feeling under the weather and has severe symptoms then parents consult a paediatrician to avoid any complications from water-borne diseases, typhoid and hepatitis.

Lastly, you must take your child’s vaccination schedule seriously. In case you’ve missed out on any, schedule an appointment immediately.